Thomas Pietschmann

5.3k citations
112 papers · 3.5k indexed · 2 hit papers · h-index 32

Thomas Pietschmann

109 papers receiving 3.4k citations

Hit Papers

Critical challenges and emerging opportunities in...1312012202620162021100200300400

Peers

Thomas Pietschmann
Comparison fields: 5 of 128
  • Hepatology 1.6k
  • Virology 293
  • Epidemiology 1.4k
  • Infectious Diseases 683
  • General Dentistry 41
Replace Ming‐Fu Chang with:
Ming‐Fu Chang Taiwan
Yoshio Mori Japan
Jörg Steinmann Germany
Martina Friesland Germany
Thomas Pietschmann Germany
Philip Meuleman Belgium
Seung‐Yong Park South Korea
Gilles Duverlie France
Shan Cen China
Ying Zhu China
Thomas Pietschmann relative to Ming‐Fu Chang Taiwan Ming‐Fu Chang's profile →
Citations per field
00.5×3.7×
Ming‐Fu Chang · 1×
Citations per year

Countries citing papers authored by Thomas Pietschmann

Since Specialization
Citations

This map shows the geographic impact of Thomas Pietschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pietschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pietschmann more than expected).

Fields of papers citing papers by Thomas Pietschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pietschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pietschmann. The network helps show where Thomas Pietschmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Pietschmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Pietschmann Line = papers co-authored together Thomas Pietschmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20230
3 20235
4 202210
5 20224
6 2021146
7 202117
8 202015
9 20196
10 201912
11 20172
12 2017158
13 201641
14 201539
15 201522
16 201444
17 201314
18 201369
19 201215
20 20093

About Thomas Pietschmann

Thomas Pietschmann is a scholar working on Hepatology, Virology and Epidemiology, having authored 112 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (71 papers), Hepatitis B Virus Studies (39 papers), Liver Disease Diagnosis and Treatment (23 papers), Respiratory viral infections research (13 papers), HIV Research and Treatment (12 papers), interferon and immune responses (11 papers), Systemic Lupus Erythematosus Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Hepatology (1.6k citations), Virology (293 citations) and Epidemiology (1.4k citations). Thomas Pietschmann has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Eike Steinmann, Gabrielle Vièyres, Jan Buer, Jörg Steinmann, Richard J. P. Brown, Ralf Bartenschlager, Stephanie Pfaender, Gisa Gerold, Florian W. R. Vondran and Lars Kaderali. Their work appears in journals such as Journal of Virology, Journal of Hepatology, Hepatology, PLoS Pathogens and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026